Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- From: J <pitstop@xxxxxxxx>
- Date: Thu, 15 Sep 2005 16:31:26 -0400
Rachel@xxxxxxxxxxxx wrote:
>
> My name is Rachel Best. I am the Executive Director of The Elka Best
> Foundation, whose sole purpose is to fund research and education in the
> use of kinder, gentler chemotherapy. "IPT Low Dose Chemotherapy" is an
> approach that uses FDA approved chemotherapy drugs that we know works
> for many people.
>
> I am an ovarian cancer survivor. I credit "IPT Low Dose Chemotherapy"
> with the miracle that I am still here and thriving.
>
> In 2001 my oncologist's prognosis for my survival was bleak, at best.
> Nevertheless, he laid out a program of surgery and chemotherapy for me
> to follow.
>
> You have probably read about how with standard treatment they give you
> as much drug as your body can tolerate. What that means is that they
> are giving you enough poison in the hope that it will kill the cancer
> but that means it is also killing your normal cells. Conventional
> chemotherapy kills your immune system almost every time. You are then
> exposed to the dangers of collateral infections... one of the biggest
> killers in cancer patients.
>
> Your oncologist knows all of this.
>
> I underwent surgery and conventional chemotherapy when I was originally
> diagnosed. It was horrible. While recovering from the surgery I almost
> died from a staph infection. Then came the chemotherapy. I lost my
> hair, was constantly nauseous and vomiting. My immune system
> diminished to the point of non existence. Once the chemotherapy was
> done, I was bedridden for most of the day for 6 months. It took me
> another 12 months to get the toxicity out of my body and recover some
> semblance of energy for life and work.
>
> By that time I was in recurrence and being recommended to have another
> surgery followed by chemotherapy. I had faced death twice and now they
> were asking me to do it again. I was terrified and would rather have
> faced the disease than their "cure". My story is like so many others.
Here's where you lose me (on your testimonial)
What date was the recurrence diagnosed? Where's the pathology report?
Where's the labwork reports?
What was your FSH and LH levels after the first surgery?
What were the levels upon "recurrence"?
You have website. You could put these information(s) and/or other relevant
ones on your website
, so we can view the proof. Or email
http://www.home.gil.com.au/~moringa/index.htm with the information.
All I can find is a small (30 ) perhaps carefully selected patients in
Uruguay
Cancer Chemother Pharmacol (2004) 53: 220?224
Insulin-induced enhancement of antitumoral response to methotrexate in
breast cancer patients
Abstract Purpose: It has been reported that insulin increases the cytotoxic
effect in vitro of methotrexate by as
much as 10,000-fold. The purpose of this study was to explore the clinical
value of insulin as a potentiator of
methotrexate. Patients and methods: Included in this prospective,
randomized clinical trial were 30 women
with metastatic breast cancer resistant to fluorouracil + Adriamycin +
cyclophosphamide and also resistant to
hormone therapy with measurable lesions. Three groups each of ten patients
received two 21-day courses of the
following treatments: insulin + methotrexate, methotrexate, and insulin,
respectively. In each patient, the size
of the target tumor was measured before and after treatment according to
the Response Evaluation Criteria
In Solid Tumors. The changes in the size of the target tumor in the three
groups were compared statistically.
Results: Under the trial conditions, the methotrexate treated group and the
insulin-treated group responded
most frequently with progressive disease. The group treated with insulin +
methotrexate responded most
frequently with stable disease. The median increase in tumor size was
significantly lower with insulin +
methotrexate than with each drug used separately.
Discussion: Our results confirmed in vivo the results of previous in vitro
studies showing clinical evidence that
insulin potentiates methotrexate under conditions where insulin alone does
not promote an increase in tumor
growth. Therefore, the chemotherapy antitumoral activity must have been
enhanced by the biochemical
events elicited in tumor cells by insulin. Conclusions: In
multidrug-resistant metastatic breast cancer, methotrexate
+ insulin produced a significant antitumoral response that was not seen
with either methotrexate or
insulin used separately.
I'll post the link to it if Peter or Steph want to have a look...
I think I'd require more than that before paying $10 or $20,000 for a
treatment.
J
.
- Follow-Ups:
- Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- From: Rachel
- Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- From: Steph
- Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- References:
- Low Dose Chemotherapy with NO SIDE EFFECTS
- From: Cancersearch
- Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- From: Rachel
- Low Dose Chemotherapy with NO SIDE EFFECTS
- Prev by Date: Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- Next by Date: multiple pulmonary nodules
- Previous by thread: Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- Next by thread: Re: Low Dose Chemotherapy with NO SIDE EFFECTS
- Index(es):
Relevant Pages
|